PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 183 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,146,000 | -1.5% | 184,753 | -0.3% | 0.01% | 0.0% |
| Q3 2016 | $4,208,000 | -3.8% | 185,301 | -0.0% | 0.01% | -16.7% |
| Q2 2016 | $4,374,000 | +23.9% | 185,339 | +7.1% | 0.01% | +20.0% |
| Q1 2016 | $3,530,000 | -58.6% | 173,046 | +4.4% | 0.01% | -54.5% |
| Q4 2015 | $8,528,000 | +30.1% | 165,747 | +7.8% | 0.01% | +22.2% |
| Q3 2015 | $6,555,000 | -8.0% | 153,805 | -1.7% | 0.01% | 0.0% |
| Q2 2015 | $7,125,000 | +48.6% | 156,428 | +23.8% | 0.01% | +50.0% |
| Q1 2015 | $4,796,000 | +46.0% | 126,341 | +8.9% | 0.01% | +50.0% |
| Q4 2014 | $3,285,000 | +29.1% | 115,987 | +15.2% | 0.00% | 0.0% |
| Q3 2014 | $2,545,000 | -13.1% | 100,666 | +0.3% | 0.00% | 0.0% |
| Q2 2014 | $2,929,000 | +270.8% | 100,380 | +229.0% | 0.00% | +300.0% |
| Q1 2014 | $790,000 | +2.5% | 30,512 | +1.9% | 0.00% | 0.0% |
| Q4 2013 | $771,000 | +4.8% | 29,946 | +8.9% | 0.00% | 0.0% |
| Q3 2013 | $736,000 | +19.1% | 27,497 | +9.3% | 0.00% | 0.0% |
| Q2 2013 | $618,000 | – | 25,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |